| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/13/2000 | WO2000019985A2 New sustained release oral formulations |
| 04/13/2000 | WO2000019984A2 Coated medicament forms with controlled active substance release |
| 04/13/2000 | WO2000019983A1 Tablets and process for producing tablets |
| 04/13/2000 | WO2000019982A1 Spray coated microparticles for use in needleless syringes |
| 04/13/2000 | WO2000019981A1 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
| 04/13/2000 | WO2000019980A1 Glucoside paucilamellar vesicles |
| 04/13/2000 | WO2000019979A1 Foamable formulation and foam |
| 04/13/2000 | WO2000019978A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 04/13/2000 | WO2000019977A1 Composition and method for medicated chewing gum delivery system |
| 04/13/2000 | WO2000019976A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 04/13/2000 | WO2000019975A1 Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients |
| 04/13/2000 | WO2000019963A1 Capsules |
| 04/13/2000 | WO2000019941A1 Buffered resorbable internal fixation devices and methods for making material therefore |
| 04/13/2000 | WO2000000159A3 Method of treatment for dermatological disorders |
| 04/13/2000 | WO1999053897A3 Topical formulation comprising poloxamers and further microbicides, and an applicator |
| 04/13/2000 | DE19847252A1 Controlled administration of testosterone, e.g. for hormone replacement therapy, using buccal bioadhesive system containing testosterone ester(s) to give targeted release profile |
| 04/13/2000 | DE19846825A1 Rieselfähige Methionin-haltige Formlinge und Verfahren zu deren Herstellung Pourable methionine-containing shaped bodies and processes for their preparation |
| 04/13/2000 | CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | CA2346332A1 Oxybutynin formulations and methods of use |
| 04/13/2000 | CA2345945A1 Spray coated microparticles for use in needleless syringes |
| 04/13/2000 | CA2345808A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | CA2345789A1 New crystal modification iii of torasemide |
| 04/13/2000 | CA2345729A1 Pharmaceutical compositions containing paclitaxel |
| 04/13/2000 | CA2345240A1 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 04/13/2000 | CA2318047A1 Tape material for transcutaneous absorption |
| 04/13/2000 | CA2285818A1 Composition to enhance skin permeation of topical skin agents |
| 04/12/2000 | EP0992490A1 Flowable formed methionine products and method for producing the same |
| 04/12/2000 | EP0992252A2 Lubricious, drug-accommodating coating |
| 04/12/2000 | EP0992244A1 Polylactic acid scleral plugs |
| 04/12/2000 | EP0992240A1 Therapeutic agent for erection failure |
| 04/12/2000 | EP0992237A2 Neohesperidine dc as cristallisation inhibitor |
| 04/12/2000 | EP0992235A1 Cometic composition |
| 04/12/2000 | EP0991705A1 Open pore biodegradable matrices |
| 04/12/2000 | EP0991659A1 Peptides and compounds that bind to the il-5 receptor |
| 04/12/2000 | EP0991641A1 Omeprazole sodium salt |
| 04/12/2000 | EP0991616A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS |
| 04/12/2000 | EP0991415A1 Orally administrable solid ribavirin dosage forms and process for making them |
| 04/12/2000 | EP0991411A1 Treatment for pulmonary fibrosis |
| 04/12/2000 | EP0991409A1 Controlled release pharmaceutical compositions containing tiagabine |
| 04/12/2000 | EP0991408A1 Novel process for manufacturing paroxetine solid dispersions |
| 04/12/2000 | EP0991407A2 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations |
| 04/12/2000 | EP0991405A1 Clear, injectable formulation of an anesthetic compound |
| 04/12/2000 | EP0991404A1 Device for delivery of dermatological ingredients |
| 04/12/2000 | EP0991403A1 Use of microparticles with adsorbed antigen to stimulate immune responses |
| 04/12/2000 | EP0991402A1 Poly(vinyl alcohol) cryogel |
| 04/12/2000 | EP0991371A1 A method for treating dentures |
| 04/12/2000 | EP0799026B1 Hemolysis prevention by surfactants |
| 04/12/2000 | EP0785776B1 Preparation of protein microspheres, films and coatings |
| 04/12/2000 | EP0721479B1 Polymer membrane having a high permeability for alkanol |
| 04/12/2000 | EP0656779B1 Submicron emulsions as ocular drug delivery vehicles |
| 04/12/2000 | CN1250436A Process for preparing aromatic polyamine mixtures |
| 04/12/2000 | CN1250378A Pharmaceutical compositions |
| 04/12/2000 | CN1250377A Hydrophilic binary systems for the administration of cyclosporine |
| 04/12/2000 | CN1250374A Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| 04/12/2000 | CN1250373A Composition and method for suppelmenting testosterone in women with symptoms of testosterone deficiency |
| 04/12/2000 | CN1250372A Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 04/12/2000 | CN1250371A Pharmaceutical compositions for controlled release of active substances |
| 04/12/2000 | CN1250370A Aqueous suspension for nasal administration of loteprednol |
| 04/12/2000 | CN1250369A Method of treating dry eye disease with purinergic receptor agonists |
| 04/12/2000 | CN1249951A Coated aquocomposition and method for preparing solid medicine |
| 04/12/2000 | CN1249950A Preparation of pharmaceutical active granules |
| 04/12/2000 | CN1249945A Throat smoothing candy made of sterculia scaphigera |
| 04/12/2000 | CN1249934A Thermal stabilized antiacid and deaired suspensoid agent |
| 04/12/2000 | CN1249930A Diclofenac potassium gel and ointment and the preparation thereof |
| 04/12/2000 | CN1051240C Hypnotic health bath lotion containing chinese medicine |
| 04/12/2000 | CN1051239C Antihypertensive health bathing vinegar |
| 04/12/2000 | CN1051238C Inhalant volatile-oil composition, medicine core and relevant health article containing the same medicine core |
| 04/12/2000 | CN1051230C Medicine for preventing and curing pregnancy of monster |
| 04/12/2000 | CN1051228C Novel medical composition containing hyaluronic acid associates and its preparing process |
| 04/12/2000 | CN1051225C Stable gastric acid tolerance-Omeprazole microgranules composition and its preparation method |
| 04/12/2000 | CN1051224C Lyophilized bougie and producing process thereof |
| 04/11/2000 | US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress |
| 04/11/2000 | US6048908 Hydrophilic polymeric material |
| 04/11/2000 | US6048888 Method and pharmaceutical formulation for treating benign prostatic hyperplasia |
| 04/11/2000 | US6048874 Parenteral metolazone formulations |
| 04/11/2000 | US6048855 Topical composition containing capsazepine |
| 04/11/2000 | US6048844 Treatment of conditions and disease |
| 04/11/2000 | US6048736 Producing a controlled drug delivery system; mixing polymers with a variety of compounds, cross-linking the polymers with biocompatible cleavage sites, incubate with compound which activates controlled release |
| 04/11/2000 | US6048729 Animal transfected clonal cells for the expression of therapeutic products |
| 04/11/2000 | US6048562 Encapsulation process |
| 04/11/2000 | US6048553 Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases |
| 04/11/2000 | US6048552 DASC compositions, process for preparing same and suspensions containing same |
| 04/11/2000 | US6048551 Microsphere encapsulation of gene transfer vectors |
| 04/11/2000 | US6048550 Hydrophilic microparticles and methods to prepare same |
| 04/11/2000 | US6048549 Powder compositions |
| 04/11/2000 | US6048548 Sustained release heterodisperse hydrogel systems-amorphous drugs |
| 04/11/2000 | US6048547 Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient |
| 04/11/2000 | US6048546 Mixing tetramethoxysilane, water, and hydrochloric acid; gelation, encapsulation; forming silica sol |
| 04/11/2000 | US6048545 Administering uncharged dye and anesthetic |
| 04/11/2000 | US6048541 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 04/11/2000 | US6048536 Vaccine compositions |
| 04/11/2000 | US6048522 Heterogeneous vinyl polymer in silicone oil solvent; oil in water emulsions |
| 04/11/2000 | US6048521 Copolymers of tyrosine-based polyarlates and poly(alkylene oxides) |
| 04/11/2000 | US6048515 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 04/11/2000 | CA2182086C Use of mometasone furoate for treating airway passage and lung diseases |
| 04/11/2000 | CA2168260C Biphasic multilamellar lipid vesicles |
| 04/11/2000 | CA2032923C Long-term delivery device including loading dose |
| 04/11/2000 | CA2009579C Insulin analogs |
| 04/10/2000 | CA2285820A1 Pourable methionine-containing shaped bodies and process for the production thereof |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |